SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Nancy McKinney who wrote (5956)11/20/1998 11:37:00 AM
From: Dauntless  Read Replies (1) of 7041
 
Nancy - In answer to your question

I called IR and was told the following

1- A small trial of the oral product in women was conducted under the Vasomax IND.
2- A small dosage study has been conducted in Mexico.
3- An IND study on the feminine product will start before year end.

This information has been freely discussed at public meetings for months.

If you believe, as I do, that this company is well positioned (product-wise), financed and managed, then this would be a good time to pick some up. Oh, I guess it's time to update the scorecard for Zonagen vs. the screaming shorts.

Zonagen will NEVER get a marketing partner - they did
Zonagen will NEVER get a patent for Vasomax - they did
Zonagen will NEVER get a patent for Chitosan - they did
Zonagen will NEVER file their NDA - they did
Zonagen will NEVER buy back a single share of their stock - they did
Zonagen will NEVER have appreciable sales in Mexico - they did
Zonagen will NEVER get their NDA accepted - they did
Zonagen is a one product company - viva VASOMAXINE!!!

The facts are hell, huh??
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext